We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
Nicholas Piramal Enters into a Joint Venture with ARKRAY Inc Japan
News

Nicholas Piramal Enters into a Joint Venture with ARKRAY Inc Japan

The 49:51 joint venture aims at marketing diagnostic products, mainly self-monitoring blood glucose system in the Indian market.
BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology
News

BD Acquires Right to Negotiate Business Relationship for Accelr8’s BACcel® Technology

Becton Dickinson has purchased an exclusive right to negotiate for a business relationship to develop Accelr8’s BACcel® rapid diagnostic platform.
Cancer Cell Line Developed that is Resistant to new Cancer Therapy
News

Cancer Cell Line Developed that is Resistant to new Cancer Therapy

Researchers found the HDAC inhibitor-resistant cell line resistant to many therapies but highly sensitive to heat shock protein 90 inhibitors, another emerging cancer treatment.
ImmunoVaccine Technologies to Acquire Immunotope
News

ImmunoVaccine Technologies to Acquire Immunotope

The acquisition will bring together IVT's signature VacciMax® platform with Immunotope's portfolio of immunotherapeutic antigens and antigen discovery platform.
Beckman Coulter Collaborates in Multisite Research Project for Cardiovascular Disease Markers
News

Beckman Coulter Collaborates in Multisite Research Project for Cardiovascular Disease Markers

The collaborative research will seek to discover genetic signatures for cardiovascular disease and obesity-related hypertension.
AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project
News

AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project

Agreement highlights growing interest in novel biology platform that identifies clinical response of cancer drugs.
Buck Institute and Neurobiological Technologies Partner to Develop Treatment for Huntington's Disease
News

Buck Institute and Neurobiological Technologies Partner to Develop Treatment for Huntington's Disease

The research involves fibroblast growth factor-2 (FGF-2), a naturally occurring protein that has been studied extensively for its neuroprotective properties.
IPSOGEN to Undertake Pilot Study on JAK2 Cancer Biomarker with Astrazeneca
News

IPSOGEN to Undertake Pilot Study on JAK2 Cancer Biomarker with Astrazeneca

The pilot agreement with AstraZeneca to evaluate molecular services and products in cancer research.
Vermillion Announces Issuance of U.S. Patent Covering Method for Aiding Diagnosis of Kidney Disorder
News

Vermillion Announces Issuance of U.S. Patent Covering Method for Aiding Diagnosis of Kidney Disorder

The U.S. Patent office has issued Vermillion U.S. Patent No. 7,297,556 for aiding diagnosis of nephrotic syndrome.
ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology
News

ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology

ImmunoCellular has entered into an agreement with Molecular Discoveries covering the IMUC’s acquisition of all monoclonal antibody related technology owned by MDC.
Advertisement